Trastuzumab-based treatmentsTrastuzumab deruxtecantrastuzumab-deruxtecanHER2-low breast cancerHER2-low tumorstrastuzumabhuman breast cancermetastatic breast cancerU of North Texas
…xpressing tumors, do not depend on HER2 signaling for survival. Trastuzumab-based treatments have failed to improve the outcomes of patients with HER2-low b…